UBS Group’s ICU Medical ICUI Stock Holding History

UBS Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,400	Closed	-$3.26M	–	8246
2019 Q3	$3.26M	Buy	+20,400	New	+$4.06M	﹤0.01%	2801

Other funds holding ICUI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's ICUI Position: Q2 2026 in Review

UBS Group reduced its ICU Medical (ICUI) stake by 13% in Q2 2026, selling an estimated $1.97M and leaving 99,012 shares worth $14.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3025.

UBS Group first reported a position in ICUI in Q4 2014 and has held it in 47 quarters since. The position peaked at $46.4M in Q3 2025. 289 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

UBS Group held 99,012 shares of ICU Medical worth $14.5M as of Q2 2026.
UBS Group sold 15,126 ICU Medical shares in Q2 2026, an estimated $1.97M.
ICU Medical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3025 holding.
UBS Group first reported a position in ICU Medical in Q4 2014 and has held it in 47 quarters since.
UBS Group's ICU Medical position peaked at $46.4M in Q3 2025.
289 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.